Evidence map›Paper›PMID 40611865›Full record

ArticleSage open aging

The Caregiving Burden of Japan's Older Population Living With Valvular Heart Disease.

Sarah Chan, Amy Meshulam, Bella Ling, Aya Ono, Juliet Smyth, William Brown, Rui Min Fung, Bruce Crawford

Abstract read
In one paragraph

Article in Sage open aging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah ChanEdwards Lifesciences, Singapore.
Amy MeshulamEdwards Lifesciences, Irvine, CA, USA.
Bella LingEdwards Lifesciences, Singapore.
Aya OnoEdwards Lifesciences, Tokyo, Japan.ORCID https://orcid.org/0009-0000-0992-6748
Juliet SmythEdwards Lifesciences, Tokyo, Japan.
William BrownVista Health, Singapore.
Rui Min FungVista Health, Singapore.
Bruce CrawfordVista Health, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging accelerates the degeneration and calcification of heart valves, driving valvular heart disease (VHD) development. As Japan's population ages, the prevalence of VHD continues to rise, increasing the burden on caregivers. This article draws on insights from the Japan Heart Health Survey (JHHS) and a targeted literature review to examine VHD's impact on caregivers who support older patients in Japan. The discussion also explores how promoting early diagnosis and treatment through medical innovations can help alleviate caregiver burden. Caregiving burden is multifaceted, impacting caregivers physically, emotionally, and financially. However, older patients often underestimate its impact. Underdiagnosis and undertreatment of VHD can exacerbate symptoms, contributing to greater caregiving strain. Low awareness among older adults and caregivers was identified as a key barrier to timely diagnosis and treatment of VHD. Leveraging advancements in medical innovation, including less invasive treatment options, could improve attitudes toward treatment, enhancing patient independence, and easing caregiving demands. Addressing the burden of VHD requires acknowledging its significant, often overlooked, impact on caregivers. Targeted public health initiatives can increase disease awareness and promote less invasive treatment options to encourage treatment. With more effective VHD management, both patients and caregivers can be adequately supported, ultimately improving health outcomes for all.

Indexed as

agingcaregiving and managementpublic health/public policyquality of life

Identifiers

PMID40611865
PMCPMC12220898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.